Phosphoinositide 3-kinases in the gut: a link between inflammation and cancer?

Trends Mol Med. 2001 Oct;7(10):455-62. doi: 10.1016/s1471-4914(01)02107-4.

Abstract

Carcinoma of the gastrointestinal tract is the most common internal malignancy affecting men and women in Western countries. Chronic intestinal inflammation, especially of the colon, is also a Western disease and correlates with a significantly increased risk of developing cancer. This has suggested that the immune processes involved in both conditions might share some common pathways. Indeed, there is increasing evidence that phosphatidylinositol 3-kinases (PI 3-kinases) are involved in both the pathogenesis of colorectal carcinoma and intestinal inflammation. Here, we discuss this rapidly progressing area of research, presenting evidence for a pivotal role of PI 3-kinase(s) in intestinal pathophysiology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Division / drug effects
  • Chemokines / metabolism
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Gastrointestinal Motility / physiology
  • Gastrointestinal Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / enzymology*
  • Gastrointestinal Neoplasms / pathology
  • Gastrointestinal Neoplasms / physiopathology
  • Humans
  • Inflammation / drug therapy
  • Inflammation / enzymology
  • Inflammation / pathology
  • Inflammation / physiopathology
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Signal Transduction

Substances

  • Chemokines
  • Enzyme Inhibitors
  • Phosphoinositide-3 Kinase Inhibitors